Qynapse

What is Qynapse?

Qynapse is a neuroimaging company that uses AI on MRI scans to diagnose, predict and monitor central nervous system disorders. Its clinical product QyScore generates automated brain biomarkers, and QyPredict is a research-only platform. QyScore is FDA-cleared Class II and CE-marked Class IIa. Qynapse has offices in Paris, Boston and Montreal.

Key capabilities of Qynapse

• QyScore volumetry: automatic labeling, visualization and volumetric quantification of brain structures
• Neurodegeneration measures: automated markers of neurodegeneration
• Neuroinflammation measures: automated markers of neuroinflammation
• 20 proprietary algorithms: built for MRI analysis
• Normative dataset: 10,000+ brain scans used as reference
• QyPredict research platform: combines genomics, biofluids, imaging and cognitive endpoints
• Regulatory compliance: HIPAA, GDPR and 21 CFR Part 11

How Qynapse works

A clinician or researcher submits brain MRI scans and QyScore automatically labels structures and quantifies volumes against a normative dataset of more than 10,000 scans, producing biomarkers to support physician decisions and patient monitoring. QyPredict is research-only and not for clinical use.

Who uses Qynapse?

Healthcare providers, pharmaceutical companies and payers use Qynapse, according to the vendor, including clinical trial teams monitoring CNS disease.

Qynapse pricing

Qynapse does not publish pricing. Contact the vendor for terms.

Qynapse alternatives

Qynapse is compared with Harrison.ai, Limbic and Mentalyc, though Harrison.ai is the closest, building clinical AI for imaging. Limbic and Mentalyc focus on mental health care rather than MRI.